Cannabis MSO – MJ Shareholders https://mjshareholders.com The Ultimate Marijuana Business Directory Wed, 10 Nov 2021 16:16:45 +0000 en-US hourly 1 https://wordpress.org/?v=6.5.5 TerrAscend Enters Into Amendment to the Membership Interest Purchase Agreement to Acquire Gage’s Licensed Operators and Extends Proxy Cut-Off for Voting at Special Meeting https://mjshareholders.com/terrascend-enters-into-amendment-to-the-membership-interest-purchase-agreement-to-acquire-gages-licensed-operators-and-extends-proxy-cut-off-for-voting-at-special-meeting/ Wed, 10 Nov 2021 16:16:45 +0000 https://www.cannabisfn.com/?p=2935868

Ryan Allway

November 10th, 2021

Uncategorized


Amendment is expected to facilitate and potentially expedite the timeframe in which the conditions for the closing of the Acquisition of Gage may be completed

Deadlines to accept proxies and revocations extended to 12:00 p.m. (Eastern time) on the date of the special meeting, November 11, 2021

TerrAscend encourages all minority shareholders to submit their votes in advance of the extended proxy cut-off; over 99% of the votes submitted by minority shareholders have been voted FOR the ordinary resolution submitted to shareholders for consideration at the TerrAscend meeting

NEW YORK and TORONTONov. 9, 2021 /CNW/ – TerrAscend Corp. (“TerrAscend” or the “Company”) (CSE: TER) (OTCQX: TRSSF), a leading North American cannabis multi-state operator, today announced that, as part of its previously announced acquisition of Gage Growth Corp. (“Gage”) (CSE: GAGE, OTCQX: GAEGF), a leading high-quality premium cannabis brand and operator, TerrAscend’s wholly-owned subsidiary (the “TerrAscend Subsidiary”) entered into an amendment (the “MIPA Amendment”) to the membership interest purchase agreement (the “MIPA”) with the owners of the licenses that Gage supports in the State of Michigan (the “Licensed Operators”).

As announced on September 1, 2021, TerrAscend entered into an arrangement agreement as amended (the “Arrangement Agreement”) for the proposed acquisition of all of the issued and outstanding securities of Gage byway of a court-approved plan of arrangement under the Canada Business Corporations Act (the “Transaction”).  As set out in TerrAscend’s management information circular dated October 4, 2021 (the “TerrAscend Circular”), concurrent with TerrAscend and Gage entering into the Arrangement Agreement, the TerrAscend Subsidiary entered into the MIPA with the Licensed Operators and the direct or indirect owner of the Licensed Operators which hold cannabis licenses and permits in connection with the Gage business (the “Seller”).

The ‘First Closing’ under the MIPA is a condition precedent for the completion of the Transaction. The purpose of entering into the MIPA Amendment is to potentially expedite achieving the ‘First Closing’ and, in turn, the completion of the Transaction, as described in more detail below. No other amendments are being made to the MIPA, the plan of arrangement or the Arrangement Agreement at this time. The  parties to the MIPA continue to have the ability to waive conditions in their favour as they may so determine. A copy of the MIPA Amendment will be filed under TerrAscend’s profile on SEDAR at www.sedar.com.

The MIPA ‘First Closing’

As set out in the TerrAscend Circular, prior to entering into the MIPA Amendment, the ‘First Closing’ was conditional upon the transfer of cannabis licenses and permits representing 70% of Gage’s revenue to Thrive Enterprises, LLC (among other conditions that must be satisfied or waived and described in more detail in the TerrAscend Circular). The MIPA Amendment allows for the 70% revenue condition to now be achieved through AEY Holdings, LLC, in addition to Thrive Enterprises, LLC. Both entities are Licensed Operators owned directly or indirectly by the Seller which hold cannabis licenses and permits in connection with the Gage business.

The MIPA Amendment was recommended by the Special Committee to the TerrAscend board of directors having determined that the MIPA Amendment is in the best interests of TerrAscend. The disinterested members of TerrAscend’s board of directors unanimously approved the MIPA Amendment.

Completion of the Transaction remains subject to court approval and the requisite approval of Gage’s and TerrAscend’s shareholders. If the requisite approvals are obtained, the Transaction will be completed as soon as possible after satisfaction or waiver of all remaining conditions precedents, including required regulatory and licensing approvals.

TerrAscend Shareholder Meeting and Extension of Deadline to Submit Proxies and Revocations

TerrAscend’s special meeting of shareholders will continue to be held virtually at https://web.lumiagm.com/235154159 (password “terrascend2021spc”) on Thursday, November 11, 2021, at 1:00 p.m. (Eastern Time) (the “TerrAscend Meeting”).

In order to permit TerrAscend shareholders the maximum opportunity to have their vote represented at the TerrAscend Meeting, the deadline for the submission of proxies or revocations of a previously submitted proxy will be extended to 12:00 p.m. (noon) Eastern time on Thursday, November 11, 2021. Shareholders are referred to the TerrAscend Circular for detailed instructions on how to vote as a registered or beneficial shareholder.

Over 99% of the votes submitted to date by minority shareholders have been voted FOR the ordinary resolution submitted to shareholders for consideration at the TerrAscend Meeting as set out in the TerrAscend Circular. TerrAscend continues to encourage all minority shareholders to submit their votes in advance of the extended proxy cut-off.

Shareholder Questions

If shareholders have any questions or require assistance with voting, please contact Laurel Hill Advisory Group, TerrAscend’s proxy solicitation agent, by telephone at 1-877-452-1784 toll-free in North America (1-416-304-0211 Outside North America) or by e-mail at [email protected], or your professional advisor.

The Canadian Securities Exchange (“CSE”) has neither approved nor disapproved the contents of this news release. Neither the CSE nor its Market Regulator (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

About TerrAscend

TerrAscend is a leading North American cannabis operator with vertically integrated operations in PennsylvaniaNew Jersey, and California, licensed cultivation and processing operations in Maryland and licensed production in Canada. TerrAscend operates an award-winning chain of The Apothecarium dispensary retail locations as well as scaled cultivation, processing, and manufacturing facilities on both the East and West coasts. TerrAscend’s best-in-class cultivation and manufacturing practices yield consistent, high-quality cannabis, providing industry-leading product selection to both the medical and legal adult-use market. The Company owns several synergistic businesses and brands, including The Apothecarium, Ilera Healthcare, Kind Tree, Prism, State Flower, Valhalla Confections, and Arise Bioscience Inc.

For more information about TerrAscend, visit www.terrascend.com.

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

This news release contains “forward-looking information” within the meaning of applicable securities laws. Forward-looking information contained in this press release may be identified by the use of words such as, “may”, “would”, “could”, “will”, “likely”, “expect”, “anticipate”, “believe, “intend”, “plan”, “forecast”, “project”, “estimate”, “outlook” and other similar expressions. Forward-looking information is not a guarantee of future performance and is based upon a number of estimates and assumptions of management in light of management’s experience and perception of trends, current conditions and expected developments, as well as other factors relevant in the circumstances, including assumptions in respect of current and future market conditions, the current and future regulatory environment, and the availability of licenses, approvals and permits.

Forward-looking statements in this news release include, but are not limited to: statements with respect to the anticipated completion of the Transaction and the timing for its completion and fulfilling certain closing conditions related to the transfer of License Assets; the timing of the TerrAscend Meeting; and the satisfaction of closing conditions which include, without limitation, approvals and closing conditions contained in the Arrangement Agreement and the MIPA (as amended). Actual results and developments may differ materially from those contemplated by these statements.

Such forward-looking statements are based on certain assumptions regarding TerrAscend and Gage, including the successful completion of the Transaction, anticipated benefits from the Transaction, and expected growth, results of operations, performance, industry trends and growth opportunities. While TerrAscend considers these assumptions to be reasonable, based on information currently available, they may prove to be incorrect.

Among other things, there can be no assurance that the Transaction will be completed or that the anticipated benefits from the Transaction will be achieved. Readers are cautioned not to place undue reliance on forward-looking statements.

Forward-looking information is subject to a variety of risks and uncertainties that could cause actual events or results to differ materially from those projected in the forward-looking information. Such risks and uncertainties include, but are not limited to, current and future market conditions; risks related to federal, state, provincial, territorial, local and foreign government laws, rules and regulations, including federal and state laws in the United States relating to cannabis operations in the United States; with respect to TerrAscend and the risk factors set out in the TerrAscend Circular, TerrAscend’s most recently filed MD&A, filed with the Canadian securities regulators and available under TerrAscend’s profile on SEDAR at www.sedar.com, and with respect to Gage, the risk factors set out in Gage’s management information circular dated October 12, 2021, Gage’s most recently filed MD&A, filed with the Canadian securities regulators and available under Gage’s profile on SEDAR at www.sedar.com

The statements in this press release are made as of the date of this release. TerrAscend disclaims any intent or obligation to update any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.

Cautionary Note Regarding Cannabis Operations in the United States

Investors should note that there are significant legal restrictions and regulations that govern the cannabis industry in the United States. Cannabis remains a Schedule I drug under the US Controlled Substances Act, making it illegal under federal law in the United States to, among other things, cultivate, distribute or possess cannabis in the United States. Financial transactions involving proceeds generated by, or intended to promote, cannabis-related business activities in the United States may form the basis for prosecution under applicable US federal money laundering legislation.

While the approach to enforcement of such laws by the federal government in the United States has trended toward non-enforcement against individuals and businesses that comply with medical or adult-use cannabis programs in states where such programs are legal, strict compliance with state laws with respect to cannabis will neither absolve TerrAscend or Gage of liability under U.S. federal law, nor will it provide a defense to any federal proceeding which may be brought against TerrAscend or Gage. The enforcement of federal laws in the United States is a significant risk to the respective business of TerrAscend and Gage and any proceedings brought against TerrAscend or Gage thereunder may adversely affect their respective operations and financial performance.

SOURCE TerrAscend

For further information: Keith Stauffer, Chief Financial Officer, [email protected]; Rob Kelly, MATTIO Communications, [email protected]

Related Links

https://www.terrascend.com/

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.


]]>
RIV Capital Closes US$150 Million Strategic Investment by The Hawthorne Collective https://mjshareholders.com/riv-capital-closes-us150-million-strategic-investment-by-the-hawthorne-collective/ Wed, 25 Aug 2021 15:10:10 +0000 https://www.cannabisfn.com/?p=2931564

Ryan Allway

August 25th, 2021


Investment strengthens balance sheet, accelerating RIV Capital’s strategy to build a
multistate cannabis operating and brand platform through acquisitions

RIV Capital common shares listed on the CSE and voluntarily de-listed from the TSX

TORONTOAug. 25, 2021 /CNW/ – RIV Capital Inc. (“RIV Capital” or the “Company“) (CSE: RIV) (OTC: CNPOF) is pleased to announce the completion of the previously announced purchase by The Hawthorne Collective, Inc. (“The Hawthorne Collective“), a cannabis-focused subsidiary of The Scotts Miracle-Gro Company (NYSE: SMG) (“ScottsMiracle-Gro“), of an unsecured convertible note (the “Convertible Note“) from RIV Capital for US$150 million (the “Investment“).

Pursuant to the Investment, RIV Capital received a capital injection of US$150 million, to be used for general corporate and other lawful purposes, that will help accelerate the launch and expansion of its U.S. cannabis operating and brand platform. The Investment also establishes RIV Capital as The Hawthorne Collective’s preferred vehicle for investments not currently under the purview of The Hawthorne Gardening Company (“Hawthorne“), ScottsMiracle-Gro’s subsidiary focused on indoor and hydroponic growing supplies.

Upon completion of the Investment, RIV Capital increased the size of its Board of Directors (the “Board“) to seven and added three nominees of The Hawthorne Collective to the Board, being Chris HagedornMark Sims and Gary Vaynerchuk.

“The closing of the investment from The Hawthorne Collective comes at a key moment for RIV Capital,” said Narbe Alexandrian, President and CEO, RIV Capital. “The ongoing uncertainty around the status of U.S. federal cannabis legalization continues to sideline significant amounts of capital, creating attractive acquisition opportunities in strategic markets. We believe we are well-positioned to capitalize on these opportunities, given our strong balance sheet and acquisition currency, and develop our operating and brand platform.”

With approximately CA$400 million in available capital,1 and taking into account certain restrictions relating to the proceeds from the Investment, RIV Capital plans to acquire, invest in, launch, and/or develop U.S. operators and brands across financially and strategically attractive states to create a multistate platform. The Company has potential near-term prospects and is engaged in discussions regarding one or more transactions that would kickstart its U.S. strategy. The Company then plans to continue building out its platform, with a focus on acquisitions of and investments in brands and plant-touching operators in limited license states and other states of strategic interest. The Company anticipates that the Investment will provide additional resources and flexibility to accelerate its go-forward strategy by pursuing parallel opportunities or acquisition targets.

As previously disclosed, the closing of the Investment was conditional on the Company’s ability to list its Class A common shares (the “Common Shares“) on the Canadian Securities Exchange (the “CSE“) and de-list its Common Shares from the Toronto Stock Exchange (the “TSX“). Accordingly, RIV Capital’s Common Shares began trading on the CSE under the symbol “RIV” on August 23, 2021 and were voluntarily de-listed from the TSX as of the close of business on August 24, 2021.

__________________________
1 Based on exchange rates as of August 23, 2021.

Early Warning Disclosure Regarding ScottsMiracle-Gro

The Convertible Note was issued to The Hawthorne Collective, a wholly-owned subsidiary of ScottsMiracle-Gro, in the principal amount of C$188,475,000 (being the Canadian dollar equivalent of US$150,000,000 based on the daily average rate of exchange for USD:CAD published by the Bank of Canada on August 9, 2021 of US$1.00 = C$1.2565). The Convertible Note will mature on August 24, 2027 (the “Maturity Date“). The Convertible Note is convertible into Common Shares at a conversion price of C$1.90 per Common Share and will bear interest at a rate of 2.03% annually until August 24, 2023, after which no interest (0.0%) will accrue for the remainder of the term. Accrued interest will be payable on the Maturity Date or will be included in the conversion value of the Convertible Note at the time of conversion.

Immediately prior to the closing of the Investment, ScottsMiracle-Gro did not beneficially own, directly or indirectly, or exercise control or direction over, any Common Shares or any securities convertible into or exercisable for Common Shares. Based on the initial principal amount of the Convertible Note, the Convertible Note is convertible into 99,197,368 Common Shares, representing approximately 41% of the outstanding Common Shares (calculated on a partially diluted basis, based on 142,468,471 Common Shares outstanding as at August 23, 2021). Including the full amount of the anticipated accrued interest over the term of the Convertible Note, the Convertible Note would be convertible into 103,224,782 Common Shares, representing approximately 42% of the outstanding Common Shares (calculated on a partially diluted basis, based on 142,468,471 Common Shares outstanding as at August 23, 2021).

ScottsMiracle-Gro indirectly acquired the Convertible Note as part of a strategic investment in the Company. ScottsMiracle-Gro intends to review its investment in the Company on a continuing basis and may, from time to time and at any time, and depending on market and other conditions, acquire or cause to be acquired additional equity or debt securities or other instruments of the Company, or dispose or cause to be disposed such equity or debt securities or instruments, through open market transactions, private placements and other privately negotiated transactions, or otherwise (including through the exercise of the Convertible Note or through exercising rights provided to The Hawthorne Collective in the Note Purchase Agreement dated August 9, 2021 between the Company and The Hawthorne Collective or the Investor Rights and Strategic Opportunities Agreement dated August 24, 2021 among the Company, The Hawthorne Collective and Hawthorne (collectively, the “Transaction Documents“)), in each case, depending on a number of factors, including general market and economic conditions and other factors and conditions ScottsMiracle-Gro deems appropriate.

The Transaction Documents also provide The Hawthorne Collective with certain governance rights relating to the Company so long as The Hawthorne Collective and its affiliates (including ScottsMiracle-Gro) collectively maintain certain levels of beneficial ownership of Common Shares (on a partially diluted basis), including the right to nominate up to three directors to the Board.

For a summary of the rights of The Hawthorne Collective under the Transaction Documents, see the material change report of RIV Capital dated August 19, 2021, which is available on RIV Capital’s SEDAR profile at www.sedar.com.

RIV Capital’s head office address is 40 King Street West, Suite 2504, Toronto, Ontario. ScottsMiracle-Gro is a corporation existing under the laws of the State of Ohio and it’s head office address is 14111 Scottslawn Road, Marysville, Ohio.

An early warning report will be filed by Hawthorne under applicable Canadian securities laws and once filed will be available on RIV Capital’s SEDAR profile at www.sedar.com. A copy of such report may also be obtained from:

Jim King
EVP & Chief Communications Officer of ScottsMiracle-Gro
937-644-0011.

About RIV Capital

RIV Capital is an operating and brand platform that aims to acquire, invest in, and develop U.S. cannabis companies to build the cannabis industry of tomorrow, today. By bringing together people, capital, and ideas, we aim to provide shareholders with exposure to exceptional cannabis companies in strategically attractive states poised for significant growth. Backed by our in-house expertise and cannabis domain knowledge, we aim to develop operators and brands who can build market share while we expand the geographic and strategic scope of our multistate platform. RIV Capital also has a strategic relationship with The Hawthorne Collective, Inc., a subsidiary of The Scotts Miracle-Gro Company, pursuant to which RIV Capital is The Hawthorne Collective’s preferred vehicle for investments not under the purview of other ScottsMiracle-Gro subsidiaries.

About The Scotts Miracle-Gro Company

With approximately $4.1 billion in sales, ScottsMiracle-Gro is one of the world’s largest marketers of branded consumer products for lawn and garden care. ScottsMiracle-Gro’s brands are among the most recognized in the industry. ScottsMiracle-Gro’s Scotts®, Miracle-Gro® and Ortho® brands are market-leading in their categories. ScottsMiracle-Gro’s wholly-owned subsidiary, The Hawthorne Gardening Company, is a leading provider of nutrients, lighting and other materials used in the indoor and hydroponic growing segment. Another wholly-owned subsidiary, The Hawthorne Collective, has been established to invest in emerging areas of the cannabis industry. For additional information, visit us at www.scottsmiraclegro.com.

Forward-Looking Statements

This news release contains statements which constitute “forward-looking information” within the meaning of applicable securities laws, including statements regarding the plans, intentions, beliefs and current expectations of the Company with respect to future business activities and operating performance. Forward-looking information is often identified by the words “may”, “would”, “could”, “should”, “will”, “intend”, “plan”, “anticipate”, “believe”, “estimate”, “expect” or similar expressions and includes, but is not limited to, information and statements regarding: the anticipated benefits of the Investment by The Hawthorne Collective; the Company’s intention to invest in, acquire and/or merge with operating U.S. cannabis companies and the value to be derived therefrom; the Company’s expectation that the Investment will accelerate growth, provide the Company with additional access to capital and optimize its investment and acquisition strategy; the Company’s expectation that it will be The Hawthorne Collective’s preferred vehicle for investments not currently under the purview of Hawthorne; the anticipated proceeds from the Investment net of transaction costs; and expectations for other economic, business, and/or competitive factors.

Investors are cautioned that forward-looking information is not based on historical fact but instead reflects management’s expectations, estimates or projections concerning future results or events based on the opinions, assumptions and estimates of management considered reasonable at the date the statements are made. Although the Company believes that the expectations reflected in such forward-looking information are reasonable, such information involves risks and uncertainties, and undue reliance should not be placed on such information, as unknown or unpredictable factors could have material adverse effects on future results, performance or achievements of the Company. Our actual financial position and results of operations may differ materially from management’s current expectations.

Among the key factors that could cause actual results to differ materially from those projected in the forward-looking information are the following: the ability of the parties to obtain, in a timely manner and on satisfactory terms, all necessary regulatory approvals required for conversion of the Note; assumptions regarding the conversion of the Note; the timing of any changes to federal laws in the United States to allow for the general cultivation, distribution, and possession of cannabis; assumptions regarding the future acquisition of Common Shares by The Hawthorne Collective pursuant to its rights under the Transaction Documents; the potential impact of the announcement or consummation of the Investment on relationships, including with regulatory bodies, stock exchanges, lenders, employees and competitors; assumptions concerning the Investment and the operations and capital expenditure plans of the Company following completion of the Investment; assumptions concerning the Company’s ability to execute its go-forward strategy; credit, liquidity and additional financing risks for the Company and its investees; stock market volatility; regulatory and licensing risks; changes in cannabis industry growth and trends; changes in the business activities, focus and plans of the Company and its investees and the timing associated therewith; the Company’s actual financial results and ability to manage its cash resources; changes in general economic, business and political conditions, including challenging global financial conditions and the impact of the novel coronavirus pandemic; competition risks; potential conflicts of interest; the regulatory landscape and enforcement related to cannabis, including political risks and risks relating to regulatory change; changes in applicable laws; changes in the global sentiment towards, and public opinion of, the cannabis industry; divestiture risks; and the other risk factors more fully described in the Company’s annual information form for the year ended March 31, 2021 and the Company’s Management’s Discussion and Analysis of Financial Results for the months ended June 30, 2021 and 2020 filed with the Canadian securities regulators and available on the Company’s profile on SEDAR at www.sedar.com.

Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward-looking information prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected. Although the Company has attempted to identify important risks, uncertainties and factors that could cause actual results to differ materially, there may be others that cause results not to be as anticipated, estimated or intended. The Company does not intend, and does not assume any obligation, to update this forward-looking information except as otherwise required by applicable law.

SOURCE RIV Capital Inc.

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.


]]>
Harvest Opens Eighth Florida Dispensary in West Palm Beach https://mjshareholders.com/harvest-opens-eighth-florida-dispensary-in-west-palm-beach/ Thu, 06 May 2021 15:03:42 +0000 https://www.cannabisfn.com/?p=2919874

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as “expects”, “will”, “anticipates”, and “estimates”; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief “snapshot” of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled “Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

]]>